You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JTT-662

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Miami (JTT-662, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • JTT-662
  • Placebo
  • Miami, Florida
    Qps-Mra, Llc
Mar 16, 2021

Chronic Heart Failure Trial in Houston (JTT-861 Capsules, Placebo Capsules)

Recruiting
  • Chronic Heart Failure
  • JTT-861 Capsules
  • Placebo Capsules
  • Houston, Texas
    East Texas Cardiology PA
Aug 24, 2023

Congenital Protein C Deficiency Trial in Kashihara, Chiba, Saitama (TAK-662)

Active, not recruiting
  • Congenital Protein C Deficiency
  • Kashihara, Nara, Japan
  • +3 more
Apr 7, 2022

Solid Tumors Trial in Charlottesville (XmAb662, Keytruda® (pembrolizumab))

Recruiting
  • Solid Tumors
  • XmAb662
  • Keytruda® (pembrolizumab)
  • Charlottesville, Virginia
    University Of Virginia Comprehensive Cancer Center
Aug 10, 2023

Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Dublin (Fampridine, Placebo)

Completed
Has Results
  • Secondary Progressive Multiple Sclerosis
  • Primary Progressive Multiple Sclerosis
  • Dublin, Dublin 4, Ireland
  • +1 more
Jul 8, 2021

Pulmonary Arterial Hypertension Trial (JTT-251, Placebo)

Withdrawn
  • Pulmonary Arterial Hypertension
  • (no location specified)
May 1, 2019

Hand Injuries Trial in Seoul (Virtual reality rehabilitation)

Completed
  • Hand Injuries
  • Virtual reality rehabilitation
  • Seoul, Yeong-deungpo-Dong, Korea, Republic of
    Hangang Sacred Heart Hospital
Oct 10, 2019

Healthy Trial (TRIA-662, Placebo)

Completed
  • Healthy
  • (no location specified)
Jul 25, 2016

Hypertriglyceridemia, Mixed Hyperlipidemia Trial in Canada (TRIA-662, Placebo)

Completed
  • Hypertriglyceridemia
  • Mixed Hyperlipidemia
  • Calgary, Alberta, Canada
  • +16 more
Jan 26, 2016

Diabetes Trial in Overland Park, Austin (JTT-252 or Placebo, JTT-252)

Terminated
  • Diabetes Mellitus
  • Overland Park, Kansas
  • +1 more
Apr 29, 2015

Diabetes Trial in Orlando (JTT-251 or Placebo)

Completed
  • Diabetes Mellitus
  • JTT-251 or Placebo
  • Orlando, Florida
    (unnamed)
Oct 3, 2014

Hyperlipidemia Trial (Low Dose TRIA-662, High Dose TRIA-662, Placebo for TRIA-662)

Completed
  • Hyperlipidemia
  • Low Dose TRIA-662
  • +2 more
  • (no location specified)
Aug 29, 2013

Type 2 Diabetes Trial in United States (JTT-851, Glimepiride, Placebo for Active)

Completed
  • Type 2 Diabetes Mellitus
  • Birmingham, Alabama
  • +78 more
Jul 25, 2013

Healthy Trial in Toronto (Niaspan, TRIA-662)

Completed
  • Healthy
  • Toronto, Ontario, Canada
    Bio Pharma Services Inc. (BPSI)
Aug 21, 2013

Type II Diabetes Trial in United States (JTT-654, JTT-654 Placebo)

Terminated
  • Type II Diabetes Mellitus
  • Birmingham, Alabama
  • +41 more
Jan 31, 2013

Type II Diabetes Trial in Worldwide (JTT-130, JTT-130 Placebo)

Completed
  • Type II Diabetes Mellitus
  • Birmingham, Alabama
  • +61 more
Jan 31, 2013

Dyslipidemia Trial in Santa Ana (JTT-302)

Completed
  • Dyslipidemia
  • Santa Ana, California
    (unnamed)
Jan 31, 2013

Dyslipidemia Trial in Santa Ana (JTT-302, Placebo)

Completed
  • Dyslipidemia
  • Santa Ana, California
    (unnamed)
Jan 31, 2013

Heart Arrest Trial in Taipei (Hydrocortisone)

Completed
  • Heart Arrest
  • Taipei, Taiwan
    National Taiwan University Hospital
Nov 30, 2012

Dyslipidemia Trial in Amsterdam (JTT-705 600 mg and simvastatin 40 mg, Placebo and simvastatin 40 mg)

Completed
  • Dyslipidemia
  • JTT-705 600 mg and simvastatin 40 mg
  • Placebo and simvastatin 40 mg
  • Amsterdam, Netherlands
    (unnamed)
Jun 2, 2008

Dyslipidemia Trial in Amsterdam (JTT-705 600 mg and atorvastatin 20 mg, Placebo and atorvastatin 20 mg)

Completed
  • Dyslipidemia
  • JTT-705 600 mg and atorvastatin 20 mg
  • Placebo and atorvastatin 20 mg
  • Amsterdam, Netherlands
    (unnamed)
Jun 2, 2008

Type II Hyperlipidemia Trial in Amsterdam (JTT-705 600 mg and pravastatin 40 mg, JTT-705 300 mg and pravastatin 40 mg, Placebo

Completed
  • Type II Hyperlipidemia
  • JTT-705 600 mg and pravastatin 40 mg
  • +2 more
  • Amsterdam, Netherlands
    (unnamed)
Jun 2, 2008

Type II Hyperlipidaemia Trial in Amsterdam (Placebo, JTT-705 300mg, JTT-705 600mg)

Completed
  • Type II Hyperlipidaemia
  • Placebo
  • +3 more
  • Amsterdam, Netherlands
    Amsterdam, Utrecht, Rotterdam, Nijmegen, Arnhem, Groningen, Dord
May 28, 2008